01 1Alivus Life Sciences
01 1MOEXIPRIL HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-03-21
Pay. Date : 2025-03-19
DMF Number : 20426
Submission : 2007-04-09
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MOEXIPRIL HYDROCHLORIDE USP, with a corresponding US DMF Number 20426.
Remarkably, this DMF maintains an Active status since its submission on April 09, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2025, and payment made on March 19, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
